Tauriga Sciences, Inc. (TAUG)

taug_logo_f_improf_179x131Many companies in the medical, wellness, and technology industries are expanding to the medical marijuana sector as it continues to show growth. Tauriga Sciences, Inc is one such company – it is a diversified biotechnology outfit that entered the marijuana space this year by acquiring a manufacturer of medical cannabis products.

Tauriga Sciences aims to build on its diversified portfolio by acquiring licenses, exclusive and non-exclusive rights, and entire businesses. Its featured subsidiaries are Microbial Robotics LLC (formerly Bacterial Robotics) and Pilus Energy LLC.

Microbial Robotics is a bio-engineering firm that ‘programs’ micro-organisms to produce microscopic robots. These can then be used in various applications such as reducing disease, cleaning water, growing foods, providing fuel, and producing therapeutics.

Meanwhile, Pilus Energy is a Tauriga-acquired subsidiary of Microbial Robotics. It uses genetically engineered bacteria that process wastewater to generate direct current electricity and produce useful gases and chemicals.

Founded in 2001, Tauriga Sciences formerly operated under various names such as New England Acquisitions, Inc, Atlantic Wine Agencies, Inc, and Novo Energies Corp. It changed to its current name in 2013.

Tauriga Sciences, Inc is now traded in the OTC markets as TAUG, with a market cap of USD 14.6 M. It is led by Dr. Stella Sung, Chairman, CEO, COO, and Interim CFO; Seth M. Shaw, VP for Strategic Planning; Dr. Lawrence A. May, Chief Medical Officer; and Ghalia Lahlou, Operations Manager. They are joined by Ian Harrison, VP and General Manager of Pilus Energy; and David Schweizer, VP of NuclearBot Development.


Yahoo! Finance: TAUG News

Latest Financial News for TAUG

Tauriga Sciences, Inc. Completes Initial Tauri-Gummies Production Run; CBD Isolate Concentration Increased to 25mg per Each Vegan Gum Drop  

NEW YORK, NY, Dec. 06, 2019 -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the.

Tauriga Sciences, Inc. to Develop a Cannabigerol CBG Infused Product to Complement its Existing CBD Infused Edibles Product Line(s)

NEW YORK, NY, Dec. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced its plans to develop a Cannabigerol (“CBG”) Infused product to complement its existing Cannabidiol (“CBD”) Isolate Infused product line(s): Tauri-Gum™ and Tauri-Gummies™. The Company may, alternatively, decide to acquire a CBG Infused product or product line – should such opportunity prove synergistic with existing business activities and infrastructure. Cannabigerol (“CBG”) is a non-psychoactive cannabinoid that plays an important role in the biochemistry of the cannabis plant.

Tauriga Sciences, Inc. to Operate Main Floor Exhibitor Booth at The Hemp World Expo at The Atlanta Expo Center North on January 18th-19th, 2020

NEW YORK, NY, Dec. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today confirmed that it will be an Exhibitor at The Hemp World Expo (The “Hemp Expo”), which will take place on January 18-19, 2020 at the following venue:  The Atlanta Expo Center North/ Atlanta, Georgia. As an Exhibitor (Booth # 460) at The Hemp Expo, the Company will operate its own booth on the main floor, from which it will sell Tauri-Gum™ (Proprietary CBD Infused Chewing Gum/3 Distinct Flavors) to potential industry customers, distributors, dispensaries, and retail chains as well as provide samples to attendees.

Tauriga Sciences, Inc. Finalizes the Formulation for its 15mg Vegan CBD Infused Gummies; Product Branded as: Tauri-Gummies

NEW YORK, NY, Nov. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has finalized the formulation for its Vegan 15mg CBD (Isolate) Infused Gummies; product to be branded under the following name: Tauri-Gummies™. The Company has worked with great diligence, the past several months, to finalize a Vegan formulation for its CBD infused Gummies product.

Tauriga Sciences, Inc. Finalizes its Alternative Tauri-Gum Package Designs and Focuses on Large National Retail Chains

New York, NY, Nov. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that is has finalized its alternative Tauri-Gum™ package designs and continues to focus efforts on securing potential orders from large national retail chains (“national retailers”). The Company has established an alternative package design for its 3 blister pack flavors (Mint, Blood Orange and Pomegranate), which essentially removes the decorative cannabis leaves – while substituting images of each respective fruit/plant.